Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02197897 · ClinicalTrials.gov registry record · Phase 2
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
A Phase 2 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT02197897 is a Phase 2 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 15 participants.
The verdict
NCT02197897, a Phase 2 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
Evaluate the treatment of tamoxifen of low/intermediate-risk bladder tumors
Interventions
- DRUG Tamoxifen Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-04-01 |
| Est. Completion | 2019-06-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02197897
The ClinicalTrials.gov registry entry for NCT02197897 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tamoxifen Citrate is the first listed.
NCT02197897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02197897 about?
NCT02197897 is a clinical study titled "Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors". Evaluate the treatment of tamoxifen of low/intermediate-risk bladder tumors
What is the current status of trial NCT02197897?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2015-04-01. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT02197897?
The interventions under investigation include: Tamoxifen Citrate (DRUG).
Who is sponsoring clinical trial NCT02197897?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.